Oncotelic Therapeutics, Inc. (OTLC)
0.0388
0.00 (0.00%)
USD |
OTCM |
May 07, 11:36
Oncotelic Therapeutics Cash from Investing (Quarterly) : 0.00 for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | -25.54M |
| Johnson & Johnson | -1.04B |
| Supernus Pharmaceuticals, Inc. | -19.22M |
| Sarepta Therapeutics, Inc. | 96.21M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.783M |
| Cash from Financing (Quarterly) | 0.4629M |
| Free Cash Flow | -1.383M |
| Free Cash Flow Per Share (Quarterly) | -0.0018 |
| Free Cash Flow to Equity (Quarterly) | -0.5042M |
| Free Cash Flow to Firm (Quarterly) | -0.6152M |
| Free Cash Flow Yield | -8.25% |